Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,812 | 3,074 | 3,045 | 1,676 | 19,015 |
| Depreciation Amortization | 4,418 | 3,278 | 2,137 | 1,014 | 4,006 |
| Income taxes - deferred | -849 | -294 | 233 | 71 | -11,732 |
| Accounts receivable | 232 | 1,910 | 1,289 | 1,112 | -1,088 |
| Accounts payable and accrued liabilities | 69 | 321 | 299 | 696 | 56 |
| Other Working Capital | -3,854 | -4,362 | -3,802 | -2,167 | -1,237 |
| Other Operating Activity | 2,820 | 78 | -406 | -1,258 | 3,273 |
| Operating Cash Flow | $6,648 | $4,005 | $2,795 | $1,144 | $12,293 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,481 | -1,131 | -848 | -425 | -813 |
| Net Acquisitions | -5,465 | -5,165 | N/A | N/A | -7,115 |
| Other Investing Activity | -252 | -154 | -140 | -125 | -418 |
| Investing Cash Flow | $-7,198 | $-6,450 | $-988 | $-550 | $-8,346 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 0 | 0 | 10,350 |
| Debt Repayment | -1,708 | -1,703 | -900 | -901 | -5,663 |
| Common Stock Issued | 567 | 449 | 327 | 0 | 282 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -5,000 |
| Financing Cash Flow | $-1,141 | $-1,254 | $-573 | $-901 | $-31 |
| Exchange Rate Effect | -97 | 232 | 809 | 691 | -800 |
| Beginning Cash Position | 19,704 | 19,704 | 19,704 | 19,704 | 16,588 |
| End Cash Position | 17,916 | 16,237 | 21,747 | 20,088 | 19,704 |
| Net Cash Flow | $-1,788 | $-3,467 | $2,043 | $384 | $3,116 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,648 | 4,005 | 2,795 | 1,144 | 12,293 |
| Capital Expenditure | -1,506 | -1,152 | -866 | -444 | -844 |
| Free Cash Flow | 5,142 | 2,853 | 1,929 | 700 | 11,449 |